Background: Primary Sjögren’s Syndrome (pSS) is an autoimmune disease, for which Traditional Chinese Medicine has shown significant therapeutic effects based on different syndrome types of Sjögren’s Syndrome. However, the research findings between it and related plant extracts are limited. Objective: To explore the symptoms of patients with yin deficiency syndrome and non-yin deficiency syndrome of Sjögren’s Syndrome and their relationship with plant extracts under the background of Traditional Chinese Medicine. Methods: Whole blood samples were collected from SS patients with yin deficiency syndrome (5), SS patients without yin deficiency syndrome (5), and healthy volunteers (5) for proteomic testing. Using healthy volunteers as the control group, the differential protein expression of SS with yin deficiency syndrome was screened for enrichment analysis and functional annotation; combining previous effective clinical cases and prescription drugs for data mining and network pharmacological analysis, potential effective plant extracts were screened and enriched. Finally, molecular docking was used to validate the results of network analysis, providing a highly probable new idea for the correlation between potential drug targets for SS patients with yin deficiency syndrome and potential effective plant extracts. Results: 1. By analyzing the proteomic data of clinical samples, the differential genes of healthy individuals versus Sjögren’s Syndrome with yin deficiency versus Sjögren’s Syndrome without yin deficiency were discovered. By overlapping the above data, it was found that the key target genes for treating Sjögren’s Syndrome are HBA1, MST1, PCSK9, and HBB. 2. Enrichment analysis of plant extracts (PE) through clinical data mining of effective cases revealed the tremendous potential of four Chinese botanical drug - β-sitosterol, quercetin, berberine, and kaempferol in treating Sjögren’s Syndrome patients with yin deficiency syndrome. 3. The pathogenesis and regulation of Sjögren’s Syndrome with yin deficiency syndrome may be related to interleukin-related pathways, DNA synthesis, and oxidative stress. 4. Molecular docking suggests that berberine has good binding activity with MST1. Conclusion: We believe that berberine and MST1 may have significant research value in the treatment of Sjögren’s Syndrome with Female Patients. This study provides valuable reference points for future research on Sjögren’s Syndrome with yin deficiency syndrome.
Read full abstract